BioCardia, Inc. Logo

BioCardia, Inc.

Develops cell-derived therapeutics for cardiovascular and pulmonary diseases.

BCDA | US

Overview

Corporate Details

ISIN(s):
US09060U5074
LEI:
Country:
United States of America
Address:
320 SOQUEL WAY, 94085 SUNNYVALE

Description

BioCardia, Inc. is a clinical-stage regenerative medicine company that develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. The company's lead program is the CardiAMP® cell therapy system, an autologous therapy that uses a patient's own bone marrow cells to potentially stimulate the body's natural healing response in the heart. This therapy is primarily being evaluated for the treatment of ischemic heart failure. In addition to its autologous platform, BioCardia is also developing CardiALLO™, an allogeneic cell therapy platform using cells from qualified donors. The company's approach integrates biotherapeutic candidates with proprietary delivery systems for targeted administration.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-16 09:00
FORM 8-K
English ZIP 75.3 KB
2025-12-10 22:54
FORM 4
English ZIP 7.8 KB
2025-12-10 22:54
FORM 4
English ZIP 7.7 KB
2025-12-10 22:54
FORM 4
English ZIP 7.7 KB
2025-12-10 22:53
FORM 4
English ZIP 6.9 KB
2025-12-10 22:52
FORM 4
English ZIP 7.1 KB
2025-12-10 22:52
FORM 4
English ZIP 7.0 KB
2025-12-10 22:52
FORM 4
English ZIP 7.0 KB
2025-12-10 22:51
FORM 4
English ZIP 7.0 KB
2025-12-10 22:51
FORM 4
English ZIP 7.1 KB
2025-12-10 22:48
FORM 3
English ZIP 10.1 KB
2025-12-03 09:00
FORM 8-K
English ZIP 78.3 KB
2025-11-24 09:00
FORM 8-K
English ZIP 66.6 KB
2025-11-12 17:10
FORM 8-K
English ZIP 95.9 KB
2025-11-12 17:07
FORM 10-Q
English ZIP 757.1 KB

Automate Your Workflow. Get a real-time feed of all BioCardia, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioCardia, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BioCardia, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Acurx Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing a new class of antibiotics for priority pathogens.
United States of America
ACXP
Adaptimmune Therapeutics PLC Logo
Commercial-stage biopharma developing TCR T-cell therapies for solid tumors.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops IgY-based immune antibodies as alternatives to vaccines and antibiotics.
South Korea
179530
ADC Therapeutics SA Logo
Commercial-stage biotech developing antibody-drug conjugates for cancer therapy.
United States of America
ADCT
Addex Therapeutics Ltd. Logo
Clinical-stage biopharma developing allosteric modulators for neurological disorders.
Switzerland
ADXN
ADIAL PHARMACEUTICALS, INC. Logo
A clinical-stage biopharma developing genetically targeted therapies for addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Develops allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET
Adlai Nortye Ltd. Logo
A clinical-stage biopharma firm developing cancer immunotherapies and RAS-targeting drugs.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
Biopharmaceutical company that develops and manufactures plasma-derived biologics.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
A clinical-stage company developing gene therapies for ocular diseases.
United States of America
ADVM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.